Blood pressure and progression of chronic kidney disease: Importance of systolic, diastolic, or diurnal variation

Current Hypertension Reports

Volumn 6, Issue 5, 2004, Pages 400-404

  Mentari, Evelyn ^a   Rahman, Mahboob ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD PRESSURE MONITORING; CHRONIC KIDNEY DISEASE; CIRCADIAN RHYTHM; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; MORTALITY; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PREDICTION; PREVALENCE; PULSE PRESSURE; RENOVASCULAR HYPERTENSION; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

EID: 5444245777     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-004-0060-2     Document Type: Article

References (56)

1. Black HR: The paradigm has shifted, to systolic blood pressure. Hypertension 1999, 34: 386-387.
2. Deedwania PC: The changing face of hypertension: Is systolic blood pressure the final answer? Arch Intern Med 2002, 162: 506-508.
3. Elliott WJ: Which blood pressure measurement is more important in the elderly? Arch Intern Med 1999, 159: 1165-1166.
4. O'Rourke M, Frohlich ED: Pulse pressure: Is this a clinically useful risk factor? Hypertension 1999, 34: 372-374.
5. Izzo JL Jr, Levy D, Black HR: Importance of systolic hypertension in older Americans. Hypertension 2000, 35: 1021-1024.
6. Pastor-Barriuso R, Banegas JR, Damian J, et al.: Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality. Ann Intern Med 2003, 139: 731-739.
7. Asia Pacific Cohort Studies Collaboration: Blood pressure indices and cardiovascular disease in the Asia Pacific Region: a pooled analysis. Hypertension 2003, 42: 69-75.
8. Safar ME, London GM: Therapeutic studies and arterial stiffness in hypertension: recommendations of the European Society of Hypertension. The Clinical Committee of Arterial Structure and Function. Working Group on Vascular Structure and Function of the European Society of Hypertension. J Hypertens 2000, 18: 1527-1535.
9. Neaton JD, Blackburn H, Jacobs D, et al.: Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992, 152: 1490-1500.
10. Pickering TG: Ambulatory blood pressure monitoring. Curr Hypertens Rep 2000, 2: 558-564.
11. Burt VL, Whelton P, Roccella EJ, et al.: Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995, 25: 305-313.
12. Lloyd-Jones DM, Evans JC, Larson MG, et al.: Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 1999, 34: 381-385.
13. US Renal Data System (USRDS): USRDS 2000 Annual Data Report, National Institute of Diabetes and Digestive Diseases. Baltimore, MD: National Institutes of Health; 2000.
14. Bakris GL, Weir MR, Shanifar S, et al.: Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med 2003, 163: 1555-1565.
15. Young JH, Klag MJ, Muntner P, et al.: Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol 2002, 13: 2776-2782.
16. Perry HM Jr, Miller JP, Fornoff JR, et al.: Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 1995, 25(4 Pt 1): 587-594.
17. Jafar TH, Stark PC, Schmid CH, et al.: Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 2003, 139: 244-252.
18. Fox CS, Larson MG, Leip EP, et al.: Predictors of new-onset kidney disease in a community-based population. JAMA 2004, 291: 844-850.
19. Wright JT Jr, Bakris G, Greene T, et al.: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK Trial. JAMA 2002, 288: 2421-2431.
20. Klahr S, Levey AS, Beck GJ, et al.: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 1994, 330: 877-884.
21. Klag MJ, Whelton PK, Randall BL, et al.: Blood pressure and end-stage renal disease in men. N Engl J Med 1996, 334: 13-18.
22. Toto RD, Mitchell HC, Smith RD, et al.: "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis. Kidney Int 1995, 48: 851-859.
23. Domanski MJ, Davis BR, Pfeffer MA, et al.: Isolated systolic hypertension : prognostic information provided by pulse pressure. Hypertension 1999, 34: 375-380.
24. Franklin SS, Khan SA, Wong ND, et al.: Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999, 100: 354-360.
25. Vaccarino V, Berger AK, Abramson J, et al.: Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program. Am J Cardiol 2001, 88: 980-986.
26. Staessen JA, Thijs L, O'Brien ET, et al.: Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension. Am J Hypertens 2002, 15(10 Pt 1): 835-843.
27. James MA, Watt PA, Potter JF, et al.: Pulse pressure and resistance artery structure in the elderly. Hypertension 1995, 26: 301-306.
28. Cirillo M, Stellato D, Laurenzi M, et al.: Pulse pressure and isolated, systolic hypertension: association with micro-albuminuria. The GUBBIO Study Collaborative Research Group. Kidney Int 2000, 58: 1211-1218.
29. Seo WS, Oh HS: The circadian rhythms of blood pressure and heart rate in the hypertensive subjects: dippers and non-dippers. Yonsei Med J 2002, 43: 320-328.
30. Verdecchia P, Schillaci G, Porcellati C: Dippers versus non-dippers. J Hypertens Suppl 1991, 9: S42-S44.
31. Verdecchia P, Schillaci G, Guerrieri M, et al.: Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990, 81: 528-536.
32. Opsahl JA, Abraham PA, Halstenson CE, Keane WF: Correlation of office and ambulatory blood pressure measurements with urinary albumin and N-acetyl-beta-D-glucosaminidase excretions in essential hypertension. Am J Hypertens 1988, 1(3 Pt 3): 117S-120S.
33. Verdecchia P, Schillaci G, Boldrini F, et al.: Risk stratification of left ventricular hypertrophy in systemic hypertension using noninvasive ambulatory blood pressure monitoring. Am J Cardiol 1990, 66: 583-590.
34. Mulec H, Blohme G, Kullenberg K, et al.: Latent overhydration and nocturnal hypertension in diabetic nephropathy. Diabetologia 1995, 38: 216-220.
35. Covic A, Goldsmith DJ: Ambulatory blood pressure monitoring in nephrology: focus on BP variability. J Nephrol 1999, 12: 220-229.
36. Townsend RR, Ford V: Ambulatory blood pressure monitoring: coming of age in nephrology. J Am Soc Nephrol 1996, 7: 2279-2287.
37. Clement DL, De Buyzere ML, De Bacquer DA, et al.: Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003, 348: 2407-2415.
38. Timio M, Lolli S, Verdura C, et al.: Circadian blood pressure changes in patients with chronic renal insufficiency: a prospective study. Ren Fail 1993, 15: 231-237.
39. Jensen LW, Pedersen EB: Nocturnal blood pressure and relation to vasoactive hormones and renal function in hypertension and chronic renal failure. Blood Press 1997, 6: 332-342.
40. Cottone S, Panepinto N, Vadala A, et al.: Sympathetic overactivity and 24-hour blood pressure pattern in hypertensives with chronic renal failure. Ren Fail 1995, 17: 751-758.
41. Portaluppi F, Montanari L, Massari M, et al.: Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure. Am J Hypertens 1991, 4(1 Pt 1): 20-26.
42. Goldsmith DJ, Covic AC, Venning MC, Ackrill P: Ambulatory blood pressure monitoring in renal dialysis and transplant patients. Am J Kidney Dis 1997, 29: 593-600.
43. Covic A, Goldsmith DJ: Ambulatory blood pressure measurement in the renal patient. Curr Hypertens Rep 2002, 4: 369-376.
44. Peixoto AJ, Sica DA: Ambulatory blood pressure monitoring in end-stage renal disease. Blood Press Monit 1997, 2: 275-282.
45. Ziegler MG: Sleep disorders and the failure to lower nocturnal blood pressure. Curr Opin Nephrol Hypertens 2003, 12: 97-102.
46. Profant J, Mills PJ, Dimsdale JE: Nocturnal blood pressure dipping and beta-adrenergic receptor sensitivity. Am J Hypertens 2002, 15(4 Pt 1): 364-366.
47. Passino C, Magagna A, Conforti F, et al.: Ventricular repolarization is prolonged in nondipper hypertensive patients: role of left ventricular hypertrophy and autonomic dysfunction. J Hypertens 2003, 21: 445-451.
48. Nielsen FS, Rossing P, Bang LE, et al.: On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes 1995, 44: 783-789.
49. Hoegholm A, Kristensen KS, Bang LE, et al.: Left ventricular mass and geometry in patients with established hypertension and white coat hypertension. Am J Hypertens 1993, 6: 282-286.
50. Bianchi S, Bigazzi R, Baldari G, et al.: Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994, 7: 23-29.
51. Redon J, Liao Y, Lozano JV, et al.: Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability. J Hypertens 1994, 12: 947-953.
52. Timio M, Venanzi S, Lolli S, et al.: "Non-dipper" hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin Nephrol 1995, 43: 382-387.
53. Timio M, Lolli S, Verdura C, et al.: Circadian blood pressure changes in patients with chronic renal insufficiency: a prospective study. Ren Fail 1993, 15: 231-237.
54. Jacobi J, Rockstroh J, John S, et al.: Prospective analysis of the value of 24-hour ambulatory blood pressure on renal function after kidney transplantation. Transplantation 2000, 70: 819-827.
55. Lurbe E, Redon J, Kesani A, et al.: Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 2002, 347: 797-805.
56. Sturrock ND, George E, Pound N, et al.: Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet Med 2000, 17: 360-364.